|
1
|
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
|
Gynecol Oncol
|
2008
|
3.94
|
|
2
|
Risk factors for developing endometrial cancer after benign endometrial sampling.
|
Obstet Gynecol
|
2012
|
2.70
|
|
3
|
The learning curve of robotic hysterectomy.
|
Obstet Gynecol
|
2013
|
2.47
|
|
4
|
Premature menopause or early menopause: long-term health consequences.
|
Maturitas
|
2009
|
2.33
|
|
5
|
Prophylactic oophorectomy in premenopausal women and long-term health.
|
Menopause Int
|
2008
|
2.26
|
|
6
|
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
|
Obstet Gynecol
|
2006
|
2.18
|
|
7
|
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
|
Gynecol Oncol
|
2003
|
2.11
|
|
8
|
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors.
|
Oncogene
|
2003
|
2.00
|
|
9
|
Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.
|
Menopause
|
2008
|
1.92
|
|
10
|
Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients.
|
J Vasc Interv Radiol
|
2011
|
1.85
|
|
11
|
Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.
|
Clin Cancer Res
|
2002
|
1.57
|
|
12
|
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.
|
Mayo Clin Proc
|
2010
|
1.51
|
|
13
|
Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids.
|
Fertil Steril
|
2008
|
1.42
|
|
14
|
Identification of cervical cancer markers by cDNA and tissue microarrays.
|
Cancer Res
|
2003
|
1.33
|
|
15
|
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
|
Gynecol Oncol
|
2005
|
1.24
|
|
16
|
Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
|
J Reprod Med
|
2007
|
1.17
|
|
17
|
Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.
|
Womens Health (Lond Engl)
|
2009
|
1.16
|
|
18
|
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma.
|
Oncogene
|
2003
|
1.13
|
|
19
|
Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound.
|
Mayo Clin Proc
|
2006
|
1.08
|
|
20
|
Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
|
Gynecol Oncol
|
2004
|
1.06
|
|
21
|
Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.
|
J Am Coll Surg
|
2009
|
1.03
|
|
22
|
Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.
|
Gynecol Oncol
|
2007
|
0.96
|
|
23
|
Validation of referral guidelines for women with pelvic masses.
|
Obstet Gynecol
|
2005
|
0.95
|
|
24
|
Host genetic polymorphism analysis in cervical cancer.
|
Clin Chem
|
2002
|
0.93
|
|
25
|
Diaphragm resection for ovarian cancer: technique and short-term complications.
|
Gynecol Oncol
|
2004
|
0.91
|
|
26
|
Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma.
|
Gynecol Oncol
|
2012
|
0.90
|
|
27
|
Understanding cellular leiomyomas: a case-control study.
|
Am J Obstet Gynecol
|
2010
|
0.87
|
|
28
|
Magnetic resonance elastography of uterine leiomyomas: a feasibility study.
|
Fertil Steril
|
2010
|
0.87
|
|
29
|
Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment.
|
Gynecol Oncol
|
2008
|
0.87
|
|
30
|
Prevention, diagnosis, and treatment of cervical cancer.
|
Mayo Clin Proc
|
2007
|
0.86
|
|
31
|
The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.
|
Gynecol Oncol
|
2011
|
0.86
|
|
32
|
Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing.
|
Mayo Clin Proc
|
2005
|
0.83
|
|
33
|
Efficacy of thermal balloon ablation in patients with abnormal uterine bleeding.
|
Am J Obstet Gynecol
|
2003
|
0.83
|
|
34
|
Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon.
|
Gynecol Oncol
|
2005
|
0.83
|
|
35
|
Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas.
|
J Virol Methods
|
2005
|
0.82
|
|
36
|
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
|
Am J Obstet Gynecol
|
2011
|
0.82
|
|
37
|
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
|
Gynecol Oncol
|
2006
|
0.82
|
|
38
|
Pelvic Castleman disease presenting as vaginal occlusion.
|
Obstet Gynecol
|
2002
|
0.80
|
|
39
|
Human papillomavirus in vulvar vestibulitis syndrome.
|
J Reprod Med
|
2007
|
0.76
|
|
40
|
In reply: risk factors for developing endometrial cancer.
|
Obstet Gynecol
|
2013
|
0.75
|
|
41
|
Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
42
|
Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
|
Int J Gynecol Cancer
|
2013
|
0.75
|